Article info
PDFCommunity child health, public health, and epidemiology
The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema
- Correspondence to:
Dr H Clark
MRC Immunochemistry Unit, Department of Biochemistry, South Parks Road, University of Oxford, Oxford OX1 3QU, UK; howard.clarkbioch.ox.ac.uk
Citation
The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema
Publication history
- Accepted January 10, 2003
- First published November 11, 2003.
Online issue publication
March 22, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 Archives of Disease in Childhood